Literature DB >> 3931528

Airway obstruction and sleep apnea in Hurler and Hunter syndromes.

J Shapiro, M Strome, A C Crocker.   

Abstract

The Hurler and Hunter syndromes are two forms of mucopolysaccharidosis. Although the diseases are rare, those afflicted commonly require otolaryngologic consultation. Upper airway obstruction is often severe, progressive, and not infrequently the suspected cause of death in these patients. Four patients with these problems are presented. In all of the children, obstructive sleep apnea was a major management problem. This and other upper airway difficulties are detailed with clinical and pathological correlates.

Entities:  

Mesh:

Year:  1985        PMID: 3931528     DOI: 10.1177/000348948509400508

Source DB:  PubMed          Journal:  Ann Otol Rhinol Laryngol        ISSN: 0003-4894            Impact factor:   1.547


  11 in total

1.  Successful noninvasive ventilation and enzyme replacement therapy in an adult patient with morbus hunter.

Authors:  M Westhoff; P Litterst
Journal:  JIMD Rep       Date:  2011-12-16

2.  Upper airway obstructive disease in mucopolysaccharidoses: polysomnography, computed tomography and nasal endoscopy findings.

Authors:  F Santamaria; M V Andreucci; G Parenti; M Polverino; D Viggiano; S Montella; A Cesaro; R Ciccarelli; B Capaldo; G Andria
Journal:  J Inherit Metab Dis       Date:  2007-06-14       Impact factor: 4.982

3.  Management of Life-Threatening Tracheal Stenosis and Tracheomalacia in Patients with Mucopolysaccharidoses.

Authors:  Christoph Kampmann; Christiane M Wiethoff; Ralf G Huth; Gundula Staatz; Eugen Mengel; Michael Beck; Stefan Gehring; Torsten Mewes; Tariq Abu-Tair
Journal:  JIMD Rep       Date:  2016-07-22

Review 4.  Neurological findings in Hunter disease: pathology and possible therapeutic effects reviewed.

Authors:  S Al Sawaf; E Mayatepek; B Hoffmann
Journal:  J Inherit Metab Dis       Date:  2008-07-13       Impact factor: 4.982

Review 5.  Lysosomal storage diseases--the horizon expands.

Authors:  Rose-Mary Naaman Boustany
Journal:  Nat Rev Neurol       Date:  2013-08-13       Impact factor: 42.937

6.  Mucopolysaccharidosis type II: European recommendations for the diagnosis and multidisciplinary management of a rare disease.

Authors:  Maurizio Scarpa; Zsuzsanna Almássy; Michael Beck; Olaf Bodamer; Iain A Bruce; Linda De Meirleir; Nathalie Guffon; Encarna Guillén-Navarro; Pauline Hensman; Simon Jones; Wolfgang Kamin; Christoph Kampmann; Christina Lampe; Christine A Lavery; Elisa Leão Teles; Bianca Link; Allan M Lund; Gunilla Malm; Susanne Pitz; Michael Rothera; Catherine Stewart; Anna Tylki-Szymańska; Ans van der Ploeg; Robert Walker; Jiri Zeman; James E Wraith
Journal:  Orphanet J Rare Dis       Date:  2011-11-07       Impact factor: 4.123

7.  Glycosaminoglycan storage disorders: a review.

Authors:  Maria Francisca Coutinho; Lúcia Lacerda; Sandra Alves
Journal:  Biochem Res Int       Date:  2011-10-05

8.  Anesthesia in a child with Maroteaux-Lamy syndrome undergoing mitral valve replacement.

Authors:  Cem Sayilgan; Lale Yuceyar; Sedat Akbas; Hulya Erolcay
Journal:  Clinics (Sao Paulo)       Date:  2012       Impact factor: 2.365

Review 9.  ENT and mucopolysaccharidoses.

Authors:  Pier Marco Bianchi; Renato Gaini; Silvano Vitale
Journal:  Ital J Pediatr       Date:  2018-11-16       Impact factor: 2.638

10.  The impact of laronidase treatment in otolaryngological manifestations of patients with mucopolysaccharidosis.

Authors:  Ana Paula Fiuza Funicello Dualibi; Ana Maria Martins; Gustavo Antônio Moreira; Marisa Frasson de Azevedo; Reginaldo Raimundo Fujita; Shirley Shizue Nagata Pignatari
Journal:  Braz J Otorhinolaryngol       Date:  2015-12-17
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.